U.S. Drug Spending Growth For 2014 Is Highest In A Decade, IMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Shooting up 13.1% for the year, spending growth for prescription drugs was driven by new products, fewer patent expiries and pricing dynamics, the IMS Institute for Healthcare Informatics report says.